VANCOMYCIN HYDROCHLORIDE (Page 5 of 5)

For Oral Administration

Oral vancomycin is used in treating antibiotic-associated pseudomembranous colitis caused by C. difficile and for staphylococcal enterocolitis. Vancomycin is not effective by the oral route for other types of infections. The usual adult total daily dosage is 500 mg to 2 g given in 3 or 4 divided doses for 7 to 10 days. The total daily dose in children is 40 mg/kg of body weight in 3 or 4 divided doses for 7 to 10 days. The total daily dosage should not exceed 2 g. The appropriate dose may be diluted in 1 oz of water and given to the patients to drink. Common flavoring syrups may be added to the solution to improve the taste for oral administration. The diluted solution may be administered via a nasogastric tube.

HOW SUPPLIED/STORAGE AND HANDLING

Vancomycin Hydrochloride for Injection USP is supplied as follows:

NDC

Vancomycin Hydrochloride for Injection USP

Package Size

70436-020-82

500 mg Vial (equivalent to 500 mg vancomycin)

10 vials per carton

70436-021-82

1 g Vial (equivalent to 1 gram vancomycin)

10 vials per carton


Prior to reconstitution, store at 20° to 25°C (68° to 77°F) [See USP controlled room temperature].

ANIMAL PHARMACOLOGY

In animal studies, hypotension and bradycardia occurred in dogs receiving an intravenous infusion of vancomycin hydrochloride 25 mg/kg, at a concentration of 25 mg/mL and an infusion rate of 13.3 mL/min.

REFERENCES

1. Moellering RC, Krogstad DJ, Greenblatt DJ: Vancomycin therapy in patients with impaired renal function: A nomogram for dosage. Ann Inter Med 1981;94:343.

NORMOSOL®-M is a registered trademark of Abbott Hospital Products (Division of Abbott Laboratories).
ISOLYTE® E is a registered trademark of McGaw, Inc.

Manufactured by:
Hainan Poly Pharm. Co., Ltd., China
Guilinyang Economic Development Area, Haikou, Hainan Province, China 571127

Distributed by:
Slate Run Pharmaceuticals, LLC
Columbus, Ohio 43215

10000053/02

Revised: 05/2021

PRINCIPAL DISPLAY PANEL — 500 mg Vial Label

NDC 70436-020-82

70436-020-82
(click image for full-size original)

PRINCIPAL DISPLAY PANEL – 1 g Vial Label

NDC 70436-021-82

70436-021-82
(click image for full-size original)
VANCOMYCIN HYDROCHLORIDE
vancomycin hydrochloride injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70436-021
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN) VANCOMYCIN 1 g
Inactive Ingredients
Ingredient Name Strength
HYDROCHLORIC ACID
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70436-021-82 10 VIAL in 1 CARTON contains a VIAL
1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (70436-021-82)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA212332 06/03/2019
VANCOMYCIN HYDROCHLORIDE
vancomycin hydrochloride injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70436-020
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN) VANCOMYCIN 500 mg
Inactive Ingredients
Ingredient Name Strength
HYDROCHLORIC ACID
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70436-020-82 10 VIAL in 1 CARTON contains a VIAL
1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (70436-020-82)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA212332 06/03/2019
Labeler — Slate Run Pharmaceuticals, LLC (039452765)
Registrant — Hainan Poly Pharm. Co., Ltd. (654561638)
Establishment
Name Address ID/FEI Operations
Hainan Poly Pharm. Co., Ltd. 654561638 manufacture (70436-021), manufacture (70436-020), analysis (70436-021), analysis (70436-020)

Revised: 05/2021 Slate Run Pharmaceuticals, LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.